US FDA approves BioDelivery Sciences’ sNDA for manufacturing specification change for Bunavail
The US Food and Drug Administration (FDA) has approved BioDelivery Sciences International Inc’s Supplemental New Drug Application (sNDA) for a manufacturing specification... Read More